- Home
- AMLX vs THW Comparison
AMLX vs THW Comparison
Compare AMLX & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- THW
- Stock Information
- Founded
- AMLX 2014
- THW 2015
- Country
- AMLX United States
- THW United States
- Employees
- AMLX N/A
- THW N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- THW Finance Companies
- Sector
- AMLX Health Care
- THW Finance
- Exchange
- AMLX Nasdaq
- THW Nasdaq
- Market Cap
- AMLX 459.1M
- THW 391.1M
- IPO Year
- AMLX 2022
- THW N/A
- Fundamental
- Price
- AMLX $5.05
- THW $10.25
- Analyst Decision
- AMLX Buy
- THW
- Analyst Count
- AMLX 6
- THW 0
- Target Price
- AMLX $10.17
- THW N/A
- AVG Volume (30 Days)
- AMLX 911.0K
- THW 149.9K
- Earning Date
- AMLX 08-07-2025
- THW 01-01-0001
- Dividend Yield
- AMLX N/A
- THW 10.76%
- EPS Growth
- AMLX N/A
- THW N/A
- EPS
- AMLX N/A
- THW N/A
- Revenue
- AMLX N/A
- THW N/A
- Revenue This Year
- AMLX N/A
- THW N/A
- Revenue Next Year
- AMLX N/A
- THW N/A
- P/E Ratio
- AMLX N/A
- THW N/A
- Revenue Growth
- AMLX N/A
- THW N/A
- 52 Week Low
- AMLX $1.62
- THW $9.76
- 52 Week High
- AMLX $7.27
- THW $14.89
- Technical
- Relative Strength Index (RSI)
- AMLX 48.04
- THW 41.63
- Support Level
- AMLX $5.24
- THW $10.61
- Resistance Level
- AMLX $5.66
- THW $10.79
- Average True Range (ATR)
- AMLX 0.34
- THW 0.13
- MACD
- AMLX -0.05
- THW -0.00
- Stochastic Oscillator
- AMLX 21.97
- THW 12.61
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.